The Gross Margin of Sensei Biotherapeutics Inc (SNSE) is
7775.20%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date |
Value |
| 2025-12-31 |
7775.20%
|
| Ticker |
Name |
Value |
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
86.56%
|
|
ETNB
|
89bio Inc
|
7775.20%
|
|
GMDA
|
Gamida Cell Ltd
|
18.50%
|
|
VKTX
|
Viking Therapeutics, Inc.
|
7775.20%
|
|
950200.KQ
|
Psomagen Inc
|
24.48%
|
|
ABBV
|
AbbVie Inc.
|
71.62%
|
|
DBTX
|
Decibel Therapeutics Inc
|
7775.20%
|
|
NCNA
|
NuCana PLC
|
7775.20%
|
|
SPRB
|
Spruce Biosciences, Inc.
|
7775.20%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
13.28%
|
|
AMGN
|
Amgen Inc
|
70.78%
|
|
BLU.TO
|
BELLUS Health Inc
|
7775.20%
|
|
FBRX
|
Forte Biosciences, Inc.
|
7775.20%
|
|
OCX
|
OncoCyte Corp
|
39.34%
|
|
SMMT
|
Summit Therapeutics Inc.
|
99.95%
|
|
950220.KQ
|
Neoimmunetech Inc
|
7775.20%
|
|
AUTL
|
Autolus Therapeutics PLC
|
-26.10%
|
|
NLTX
|
Neoleukin Therapeutics Inc
|
7775.20%
|
|
SPRO
|
Spero Therapeutics, Inc.
|
7775.20%
|
|
CUE
|
Cue Biopharma, Inc.
|
7775.20%
|
|
INZY
|
Inozyme Pharma Inc
|
7775.20%
|
|
CBMG
|
Cellular Biomedicine Group Inc
|
81.65%
|
|
LCTX
|
Lineage Cell Therapeutics Inc
|
99.00%
|
|
ONCR
|
Oncorus Inc
|
7775.20%
|
|
ONCT
|
Oncternal Therapeutics Inc
|
91.24%
|
|
APS.TO
|
Aptose Biosciences Inc
|
100.00%
|
|
BYSI
|
Beyondspring Inc
|
7775.20%
|
|
MRNA
|
Moderna, Inc.
|
70.32%
|
|
ACET
|
ADICET Bio, Inc.
|
7775.20%
|
|
GILD
|
Gilead Sciences, Inc.
|
78.84%
|
|
CRDF
|
Cardiff Oncology, Inc.
|
100.00%
|
|
FHTX
|
Foghorn Therapeutics Inc.
|
7775.20%
|
|
SQZ
|
SQZ Biotechnologies Co
|
7775.20%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
86.24%
|
|
AGLE
|
Aeglea Bio Therapeutics Inc
|
7775.20%
|
|
APLT
|
Applied Therapeutics Inc
|
7775.20%
|